|Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma|
TO Nielsen, FD Hsu, K Jensen, M Cheang, G Karaca, Z Hu, ...
Clinical cancer research 10 (16), 5367-5374, 2004
|ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas|
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
|Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non …|
KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ...
The lancet oncology 12 (9), 852-861, 2011
|Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T reg cells|
A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ...
Nature 475 (7355), 226-230, 2011
|Ovarian carcinoma subtypes are different diseases: implications for biomarker studies|
M Köbel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer, S Leung, ...
PLoS medicine 5 (12), e232, 2008
|Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary|
SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ...
New England Journal of Medicine 360 (26), 2719-2729, 2009
|EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer|
L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ...
Cell 115 (5), 523-535, 2003
|Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the …|
RH Young, CB Gilks, RE Scully
The American journal of surgical pathology 15 (5), 415-429, 1991
|A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells|
RB West, BP Rubin, MA Miller, S Subramanian, G Kaygusuz, ...
Proceedings of the National Academy of Sciences 103 (3), 690-695, 2006
|Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers|
A Heravi-Moussavi, MS Anglesio, SWG Cheng, J Senz, W Yang, ...
New England Journal of Medicine 366 (3), 234-242, 2012
|Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers|
S Chia, B Norris, C Speers, M Cheang, B Gilks, AM Gown, D Huntsman, ...
J Clin Oncol 26 (35), 5697-5704, 2008
|Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling|
A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ...
The Journal of pathology 231 (1), 21-34, 2013
|Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities|
JZ Press, A De Luca, N Boyd, S Young, A Troussard, Y Ridge, P Kaurah, ...
BMC cancer 8 (1), 1-12, 2008
|Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors|
K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao, CB Gilks, PH Watson, ...
PloS one 4 (7), e6412, 2009
|Differences in tumor type in low-stage versus high-stage ovarian carcinomas|
M Köbel, SE Kalloger, DG Huntsman, JL Santos, KD Swenerton, ...
International Journal of Gynecological Pathology 29 (3), 203-211, 2010
|Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells|
BW Sutherland, J Kucab, J Wu, C Lee, MCU Cheang, E Yorida, D Turbin, ...
Oncogene 24 (26), 4281-4292, 2005
|Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.|
CB Gilks, RH Young, P Aguirre, RA DeLellis, RE Scully
The American journal of surgical pathology 13 (9), 717-729, 1989
|Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study|
W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ...
The lancet oncology 14 (9), 853-862, 2013
|Terminology of endocrine tumors of the uterine cervix|
J Albores-Saavedra, D Gersell, CB Gilks, DE Henson
Archives of pathology & laboratory medicine 121 (1), 34, 1997
|Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts|
DN Hayes, S Monti, G Parmigiani, CB Gilks, K Naoki, A Bhattacharjee, ...
Journal of Clinical Oncology 24 (31), 5079-5090, 2006